Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
- PMID: 27913630
- DOI: 10.4049/jimmunol.1601236
Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
Abstract
CMV infection in kidney transplant recipients (KTRs) has been associated with an increased risk for graft loss and reduced host survival. CMV promotes persistent expansions of NK cells expressing the CD94/NKG2C receptor. The NKG2C (KLRC2) gene is frequently deleted, and copy number influences the adaptive response of NKG2C+ NK cells. The distribution of NKG2C+ NK cells and NKG2C genotypes (NKG2C+/+, NKG2C+/del, NKG2Cdel/del) were studied in cross-sectional (n = 253) and prospective (n = 122) KTR cohorts. Assessment of CMV viremia was restricted to symptomatic cases in the retrospective study, but was regularly monitored in the prospective cohort. Overall, the proportions of NKG2C+ NK cells were significantly higher in KTRs who had suffered posttransplant symptomatic CMV infection in the cross-sectional study. Yet, along the prospective follow-up (3, 6, 12, and 24 mo), posttransplant NKG2C+ NK cell expansions were not observed in every patient with detectable viremia who received preemptive antiviral therapy, suggesting that the adaptive NK cell response may be inversely related with the degree of CMV control. Remarkably, the incidence of posttransplant viremia was reduced among cases with high pretransplant levels of NKG2C+ NK cells. The NKG2C genotype distribution was comparable in KTR and healthy controls, and greater proportions of NKG2C+ cells were detected in NKG2C+/+ than in NKG2C+/del patients. Yet, a trend toward increased NKG2C+/del and reduced NKG2C+/+ frequencies associated with symptomatic infection was appreciated in both cohorts. Altogether, our results indirectly support that adaptive NKG2C+ NK cells are involved in the control of CMV in KTRs.
Copyright © 2016 by The American Association of Immunologists, Inc.
Similar articles
-
Long-Term Evolution of the Adaptive NKG2C+ NK Cell Response to Cytomegalovirus Infection in Kidney Transplantation: An Insight on the Diversity of Host-Pathogen Interaction.J Immunol. 2021 Oct 1;207(7):1882-1890. doi: 10.4049/jimmunol.2100055. Epub 2021 Sep 1. J Immunol. 2021. PMID: 34470855
-
Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.J Immunol. 2016 May 1;196(9):3818-27. doi: 10.4049/jimmunol.1502438. Epub 2016 Mar 18. J Immunol. 2016. PMID: 26994220
-
NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.Transplantation. 2019 Mar;103(3):493-501. doi: 10.1097/TP.0000000000002450. Transplantation. 2019. PMID: 30211828 Free PMC article.
-
Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117. Eur J Immunol. 2013. PMID: 23552990 Review.
-
The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.Semin Immunol. 2014 Apr;26(2):145-51. doi: 10.1016/j.smim.2014.03.002. Epub 2014 Mar 22. Semin Immunol. 2014. PMID: 24666761 Review.
Cited by
-
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.JCI Insight. 2024 Sep 24;9(18):e180115. doi: 10.1172/jci.insight.180115. JCI Insight. 2024. PMID: 39099206 Free PMC article. Clinical Trial.
-
Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.Front Immunol. 2019 Apr 3;10:687. doi: 10.3389/fimmu.2019.00687. eCollection 2019. Front Immunol. 2019. PMID: 31001281 Free PMC article. Clinical Trial.
-
Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):e2116588119. doi: 10.1073/pnas.2116588119. Proc Natl Acad Sci U S A. 2022. PMID: 35181606 Free PMC article.
-
Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.Respir Res. 2020 Mar 4;21(1):63. doi: 10.1186/s12931-020-1323-4. Respir Res. 2020. PMID: 32131843 Free PMC article.
-
NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates.Front Immunol. 2019 Aug 23;10:1890. doi: 10.3389/fimmu.2019.01890. eCollection 2019. Front Immunol. 2019. PMID: 31507586 Free PMC article.